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ABSTRACT The space between the t-tubule invagination and the sarcoplasmic reticulum (SR) membrane, the dyad, in
ventricular myocytes has been predicted to experience very high [Ca21] for short periods of time during a Ca21 transient. The
dyadic space accommodates many protein kinases responsible for the regulation of Ca21 handling proteins of the cell. We
show in vitro that cAMP-dependent protein kinase (PKA) is inhibited by high [Ca21] through a shift in the ratio of CaATP/MgATP
toward CaATP. We further generate a three-dimensional mathematical model of Ca21 and ATP diffusion within dyad. We use
this model to predict the extent to which PKA would be inhibited by an increased CaATP/MgATP ratio during a Ca21 transient in
the dyad in vivo. Our results suggest that under normal physiological conditions a myocyte paced at 1 Hz would experience up
to 55% inhibition of PKA within the cardiac dyad, with inhibition averaging 5% throughout the transient, an effect which becomes
more pronounced as the myocyte contractile frequency increases (at 7 Hz, PKA inhibition averages 28% across the dyad
throughout the duration of a Ca21 transient).
INTRODUCTION
The calcium concentration ([Ca21]) in cardiac myocytes
varies signiﬁcantly both spatially and temporally during a
contraction. Cytosolic-free calcium ([Ca21]free) typically
averages ;150 nM at rest but increases to ;1 mM during a
contraction,with half-maximal contraction occurring at;600
nM (1). Subsequent relaxation occurs when [Ca21]free falls to
;200 nM (2). In organelles within the myocyte such as the
sarcoplasmic reticulum (SR), the [Ca21] is much more dif-
ﬁcult to measure accurately. Shannon and Bers (3) have esti-
mated the total SR [Ca21] in quiescent myocytes to be as high
as 14mMalthough the free [Ca21] in the SR lumen is likely to
be lower than this.
During contraction, Ca21 enters the myocyte through the
voltage-gated L-type calcium channels (dihydropyridine recep-
tors, DHPR) in the t-tubular invagination of the sarcolemma.
This triggers an additional, greater release of Ca21 from the
SR through the ryanodine receptors (RYR), a process termed
calcium-induced calcium release (CICR, (4)). The cell archi-
tecture is such that both Ca21 entry into the cell and Ca21
release from the SR deposit Ca21 into the cardiac dyad, the
physical space formed between the t-tubule and the opposing
SR membrane. The dyadic cleft between the t-tubule and SR
membrane is typically a gap of ;10 nm and covers an area
with a radius of 200 nm (5). These dimensions are suf-
ﬁciently small to result in restricted diffusion of soluble
components, the diffusion of which is further restricted by
the protrusion of protein domains, particularly RYR do-
mains, into the dyadic space. The movement of Ca21 in this
space has not been observed experimentally, as the kinetics
of movement and the small size of the dyad impose technical
barriers that are difﬁcult to overcome. Instead, a number of
groups has used computational methods to predict dyadic
free calcium [Ca21]dyad, which range from ;10 mM to ;7
mM (5–9).
Many proteins resident in the dyadic region are controlled
by both Ca21 and site-speciﬁc phosphorylation (10). It has
been long established that phosphorylation of DHPR increases
Ca21 current (ICa), probably by increasing the open prob-
ability (Po) of the channel (11). Ca
21 also regulates RYR.
Submicromolar Ca21 is capable of activating RYR, but the
maximal Po is reached at ;100 mM, with higher (.5 mM)
Ca21 leading to inactivation of the channel (12,13). Al-
though it is well established that both cAMP-dependent
protein kinase (PKA) and calcium-calmodulin-dependent
kinase II (CaMKII) phosphorylate RYR (14–16), the role of
phosphorylation of RYR remains a contentious issue. It has
been shown that RYR can be phosphorylated by both PKA
and CaMKII in vitro at Ser-2809 (or Ser-2808, in humans)
(14,15,17). Changes occurring upon in vitro phosphoryla-
tion at Ser-2809 are signiﬁcant, including an increased Po
(15,17), the abrogation of the inhibitory effects of cal-
modulin (CaM) (15) and Mg21 (18), an increased Ca21 sen-
sitivity of Po (19), dissociation of regulatory factors (e.g.,
FKBP12.6), expression of subconductance states, and the
expression of channel activity at diastolic [Ca21]free (17).
Clinically, hyperphosphorylation of RYR at Ser-2808 has
been described in situations such as heart failure, suggesting
abnormal control of the phosphorylation status may contrib-
ute to abnormal Ca21 handling (20), although more recent
studies in vivo have noted no increase in Ser-2808
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phosphorylation in failing canine, rat, or human hearts (21).
Ser-2030 has also been described as a target for PKA phos-
phorylation, with a recent study suggesting that it is the
major RYR phosphorylation target in response to b-adrenergic
stimulation (21). To date no effect on Ca21 handling has
been reported relating to RYR Ser-2030 phosphorylation.
The RYR channels may play a more important role in
b-adrenergic signaling as scaffold proteins, as they form a com-
plex that localizes PKA and phosphatases 1 and 2A in the dyad
(17). This is thought to ensure efﬁcient local control of the
phosphorylation status ofRYRand other neighboring proteins.
A number of protein kinases have been reported to be
affected by high [Ca21] because of the effect of Ca21 on the
level of MgATP. An increase in [Ca21] shifts the
MgATP5CaATP equilibrium toward CaATP, thus reducing
MgATP.Additionally, speciﬁcATPhydrolyzing proteins such
as Juvenile Hormone Diol kinase (22) and the H1,K1-ATPase
(23) will bind CaATP but not hydrolyze it efﬁciently. In these
enzymes CaATP blocks the access of MgATP to the catalytic
sites of the kinases and so is effectively a competitive inhibitor.
Bhatnagar et al. (24) have reported that PKA will bind CaATP
with a similar apparent afﬁnity as MgATP but cannot
hydrolyze CaATP to CaADP. These data suggest that PKA
will be competitively inhibited byCa21 (through an increase in
CaATP). If this occurs, it poses an interesting situation for
the control of dyadic proteins by phosphorylation, where the
normal extremes of [Ca21]dyad may affect kinase activity.
Herewe show that PKA activity is inhibited by high [Ca21]
as a result of an increase in [CaATP].We have also developed
a computer model of a ventricular myocyte incorporating
the dyad that allows us to predict the extent to which PKA
inhibition would occur in vivo.
METHODS
Materials
PKA was purchased from Upstate (Charlottesville, VA), PL919Y (synthetic
peptide substrate, RSAIRRASTIEY-amide) was synthesized by Neosystem
(Strasbourg, France), [g-32P]ATP was obtained from MP Biomedicals
(Irvine, CA), and P81 paper was purchased fromWhatman (Brentford, UK).
All other chemicals were purchased from Sigma-Aldrich (Poole, UK).
Phosphorylation assays
Phosphorylation reactions were conducted at 37C in 100 ml buffer
containing 400 U (1 U is 1 pmol phosphate incorporation into PL919Y at
37C per min) PKA, 0.1 mMPL919Y, and 50mM histidine (pH 7.0), 5 or 25
mMMgSO4, 6.25mMNaF, 1mMEGTA, and CaCl2 to achieve [Ca
21]free of
3 mM–10 mM (calculated using Bound and Determined (BAD) 4.42 (25)).
After 2 min of equilibration the phosphorylation reaction was initiated by the
addition of 0.1 mM [g-32P]ATP (0.1 mCi/nmol, ﬁnal concentration to 10
mM). After 1 min of incubation the reaction was terminated by the addition of
100ml 1% (v/v)H3PO4 to the sample and transferring 180ml of sample to P81
paper. P81 paperwas thenwashed43 5min in 1% (v/v)H3PO4 before drying.
Incorporated [g-32P] was determined by scintillation counting in Emulsiﬁer-
safe using a Packard TriCarb 1900TR scintillation counter, counting for 2min
per sample (both from Canberra-Packard Ltd., Pangbourne, UK).
Three-dimensional model of a sarcomere
The three-dimensional model of the half cardiac sarcomere is shown
diagrammatically in Fig. 1. The sarcomere was cylindrical in shape (radius
500 nm; length 1000 nm). Ca21 diffusion and regulatory processes were
described by the following partial differential equation, which was solved
using the implicit Euler’s method of solution
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where r, u, and z are the radial, angular, and length dimensions in a cylin-
drical coordinate system, D is the diffusion coefﬁcient, and F(r,u,z,[Ca],t) is
a function describing the position, concentration, and time-dependent Ca21
regulatory processes and buffering included in the model. Similar equations
were used to describe the diffusion of Mg21 and the Ca21 and Mg21-bound
forms of ATP and ADP in the model. The modeled cell segment was divided
into 50 radial elements (each one extending 10 nm in the radial direction),
50 length elements (10-nm long within the dyad, 20.6-nm long outside of
the dyad), and 20 (18) angular elements. The SR was represented by a disk
located 10 nm from the plasma membrane with a radius of 200 nm, and a
thickness of 20 nm in the z-direction (see Fig. 1). These dimensions are in
keeping with those reported in the literature (5). At the start of the
simulations, extracellular [Ca21] was assumed to be 1 mM, SR luminal
[Ca21] was assumed to be 0.7 mM, and resting [Ca21]free was assumed to be
100 nM (26). Euler’s method of solution of Eq. 1 requires that diffusion be
computed into one element at each position beyond the boundaries of the
model. This was achieved by setting all of the components in each element
FIGURE 1 Cartoon of the computer model representing half of a
sarcomere (Z-line to M-line). The position in the sarcomere is expressed
in cylindrical coordinates (r,z,u). The model is a cylinder with radius, r ¼
500 nm, length, z ¼ 1000 nm. The junctional SR is modeled as an
impermeable disk with radius, r1 ¼ 200 nm, depth ¼ 20 nm, situated 10 nm
from the Z-line surface. Longitudinal SR is represented as a cylinder with
radius ¼ 90 nm and length ¼ 970 nm. Free diffusion was allowed to occur
throughout the longitudinal SR; however, SERCA uptake also occurred in
this region. In r, the model is divided into 10-nm elements; in z the element
size is 10 nm above and including the SR and 20.6 nm below, radially, the
model is divided into 20 even segments. Calcium enters the model through
the 20 radial segments at r ¼ 1. Free [Ca21], CaATP, MgATP, CaADP, and
MgATP are obtained for each element at 1-ms intervals.
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beyond the boundary equal to the value at the boundary as described
previously (27).
Ca21 inﬂux and release into the dyadic space was modeled by increasing
the [Ca21] in all the radial elements where r and z ¼ 1 (i.e., the center
20 elements of the dyadic space). Ca21 entry into each of the 20 elements
was modeled using the following exponential equation:
@½Ca
@t
¼ Bet=toff3ð1 et=tonÞ; (2)
where B is a current term and toff and ton are time constants of 3 and 40 ms,
respectively (10), for the rising and falling phases of the Ca21 transient. The
current termwas chosen so that the Ca21 increase in thewholemyocyte (20 pl
volume) was 16 mM and is consistent with Ca21 increases in the literature
(5,28,29). An exponential increase and decay in [Ca21] was chosen over a
square pulse to better represent the cooperative opening and closing of both
DHPR andRYR.Ca21 removal from the cytosol in themodelwas assumed to
occur through uptake into the SR and extrusion across the plasmamembrane.
Uptake into the SRoccurred on the cytosolic surface of the SR and throughout
a cylinder (representing longitudinal SR), radius 90 nm, extending from the
dyad opposing the SR surface to the distal end of the model (Fig. 1). Uptake
into the SR mediated by SERCA was described by the Hill equation,
@½Ca
@t
¼ A 3 Vmax ½Ca
n
K
n
m1 ½Can
; (3)
where A is the number pumps per element, Km is the [Ca
21] required for
half-maximal uptake velocity, Vmax is the theoretical maximum uptake
velocity, and n is the Hill coefﬁcient for uptake (see Table 1 for values).
Extrusion across the plasma membrane occurred at the Z-line, at all
voxels outside of the dyad (z ¼ 1, r . dyad radius). Extrusion was also
described by Eq. 3, with n ¼ 1 (see Table 1 for a complete list of values).
As described previously (27), passive leak from the SR and extracellular
spaces was described by equations of the form
@½Ca
@t
¼ Kleakð½Cax  ½CafreeÞ; (4)
where [Ca]x is the free Ca
21 within the SR or in the extracellular space (set as
0.7 and 1 mM, respectively), and leak constants (Kleak) were adjusted so that
TABLE 1 Values used for mathematical model
Ion or molecule Concentration (mM) Diffusion (mm2s1)
Free Ca21 0.0001* 100 dyad*, 300 cytosol*
Free Mg21 1y 63 dyad*z, 190 cytosolz
Total ATP 7y 60 dyad*§, 180 cytosol*§
Total ADP 0.005y 60 dyad*§, 180 cytosol*§
H1 0.0001
*Peskoff and Langer (5).
yMichailova and McCulloch (7).
zBernengo et al. (35).
§Baylor and Hollingworth (30).
Metal ATP or ADP complex diffusion was assumed to be the same as free ATP or ADP.
Buffer kon (mM
1s1) koff (s
1) Concentration (mM)
Troponin C*y 32.7 19.6 70
Troponin C Ca/Mgyz 2.37 0.032 140
Myosiny 13.8 0.46 140
Calmodulin§ 34 238 24
Sarcolemma{ 100 1300 42
Membranek 100 30 15
ATP Ca** 225 45,000 7000
Mg** 125 10,875
ADP Ca** 125 193500 5
Mg** 125 84500
PKA MgATPzz 1.8 68
CaATP§§ 1.8 6 25% 68 6 25%
*Gao et al. (36).
yRobertson et al. (37).
zPan and Solaro (38).
§Haiech et al. (39).
{Post and Langer (40).
kBers (41).
**Michailova and McCulloch (7).
and zzLew et al. (31).
§§No data available; rates based on those of MgATP (see text).
Calcium removal pathway Km (mM) Vmax (mMs
1) Hill coefﬁcient
SR uptake* 0.3 210 2
Plasma membrane extrusiony 4 70 1
*Bers (10).
yBlaustein and Lederer (42).
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under resting conditions ([Ca21]free ¼ 100 nM) leak from the SR was equal to
SERCAuptake and leak into the cell was equal to plasmamembrane extrusion.
Buffering within the model was the same at all locations and was based
upon buffering components described by Bers (10) for a rabbit ventricle,
with the addition of ATP and ADP, which are capable of binding Ca21 or
Mg21 (see Table 1 for binding constants and concentrations). The action of
these buffers was described by the equation
@½X
@t
¼ konð½X3½bufferfreeÞ1 koffð½X  bufferÞ; (5)
where [X] is Ca21 or Mg21, kon and koff are the on and off rates for Ca
21 or
Mg21 binding to the buffer and [X  buffer] is the Ca21 or Mg21 bound form
of the buffer.
The apparent metal-ATP occupancy of PKA was calculated at micro-
second intervals using the above equation (with PKA acting as the buffer,
see Table 1 for binding constants and concentrations). The rate constants for
the binding of CaATP to PKA were assumed to be roughly the same as
MgATP. To account for possible differences in the rate constants, the on and
off rates for CaATP binding to PKA were varied by 625% of MgATP
values in simulations. This assumption was based upon evidence that the
apparent afﬁnities of the two species for PKA are similar (24).
RESULTS
Ca21 (CaATP) sensitivity of PKA
The effect of [Ca21] on PKA activity was examined by
measuring the phosphorylation of a peptide substrate at a
variety of [Ca21]free. Fig. 2 A shows that high [Ca
21]free
inhibits PKA activity and that this inhibitory proﬁle is
inﬂuenced by the concentration of Mg21. Raising Mg21
offered some protection to the enzyme from the inhibitory
potential of Ca21, consistent with the notion of competition
between Ca21 and Mg21. As PKA does not possess an
identiﬁed Ca21-binding site, we explored the possibility that
inhibition was achieved indirectly through competition of
Ca21 and Mg21 for ATP. As [Ca21]free increases (as in Fig.
2 A) it will shift the equilibrium of MgATP5CaATP toward
CaATP, as shown in Fig. 2 B, resulting in PKA inhibition
through both a reduction in MgATP concentration, and as a
consequence of CaATP-binding. Others have shown that
CaATP is not a substrate for the kinase (24). Fig. 2C shows the
activity of PKA from Fig. 2 A replotted against the CaATP/
MgATP ratio. The data generated with both 5mM and 25mM
Mg21 are described by the same double exponential relation-
ship, strengthening our assumption that the inhibition of PKA
is caused by the increase in the CaATP/MgATP ratio.
With the determination of the relationship between [Ca21]
and PKA activity, we sought to investigate whether the
conditions required for the inhibition of PKA occur physio-
logically. The vast majority of cellular locations can be
discounted because the [Ca21]free required to sufﬁciently alter
the CaATP/MgATP balance would never occur. The cardiac
dyad, however, may be a site where this could occur. The
dyadic cleft is a highly restricted space where high levels of
Ca21 occur transiently during excitation contraction cou-
pling. Predicted transient [Ca21]dyad in this region range be-
tween 10 mM and 7 mM (5–9). [Ca21] in this range could
signiﬁcantly alter the CaATP/MgATP ratio, resulting in the
inhibition of PKA (Fig. 2).
Computer simulation of half a sarcomere
(model validation)
Many models of the cardiac sarcomere have been developed
(see above), all of which in some way simplify the structure
FIGURE 2 Effect of [Ca21]free on PKA
activity. (A) PKA (400 U) was incubated at
a range of [Ca21]free (3 mM–10 mM) for
2 min in 50 mM histidine (pH 7.0)
containing 5 mM (d) or 25 mM (:)
MgSO4, 6.25 mM NaF, 1 mM EGTA, and
0.1 mM PL919Y. PL919Y was phosphor-
ylated for 1 min by PKA at 37C after the
addition of 0.1 mM ATP-g-32P (ﬁnal
concentration to 10 mM). The reaction
was terminated by the addition of 100 ml
1% (v/v) H3PO4. Phosphorylated PL919Y
was transferred to P81 paper, and [g-32P]
incorporation was measured by scintillation
counting. The background-corrected levels
of incorporation are shown and represent
the mean 6 SE (n ¼ 3). (B) Effect of
increasing [Ca21]free on the CaATP/
MgATP at total magnesium concentrations
of 5 (d) and 25 mM (:). The concentra-
tions of CaATP and MgATP were calcu-
lated using BAD 4.42 (25). (C) Effect of
CaATP/MgATP on PKA activity. Data
from A were replotted using the ratio
generated in B.
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to focus on a speciﬁc area of interest. In this study, we have
generated a model of a half sarcomere containing a single
dyadic cleft using morphological structures of realistic
dimensions (SR volume, dyadic area, plasma membrane
area, sarcomeric volume (5); Fig. 1) to focus on Ca21 and
CaATP movement and concentration in and around the dyad.
The spatial elements of the model are divided into voxels
using the cylindrical coordinate system (r,z,u; see Methods),
and the Ca21 ﬂux rates, Ca21 diffusion rates, and Ca21-
buffering characteristics are taken from the relevant literature
(Table 1). The model allows for the entry of Ca21 at a single
site within the dyad, its free diffusion from one voxel to
another, its uptake into the SR, and its efﬂux from the cell,
thereby generating a dynamic model of Ca21 homeostasis in
the myocyte. To assess the predictive power of this model,
and the kinetic parameters therein, we examined its ability to
simulate a realistic cytosolic Ca21 transient. Furthermore, we
assessed the stability of the model by simulating a train of
Ca21 transients (9th and 10th shown in Fig. 3 A), the 10th of
which is displayed in Fig. 3 B. A stable average cytosolic
Ca21 transient was predicted by the simulation, which rose
to a peak of 680 nM at 95 ms and declined following a
monoexponential function (t ¼ 0.67 s) to a diastolic
[Ca21]free of 220 nM. These values are similar to those
reported for ventricular myocytes, paced at 1 Hz (8) and by
other mathematical models (7,10).
[Ca21]dyad during a Ca
21 transient
The establishment of a model that accurately simulates the
average cytosolic Ca21 transient allowed us to predict the
[Ca21]dyad. The [Ca
21] in the model was calculated at 1-ms
intervals at each segment of the model (using the radial
coordinate system r,z,u). The three-dimensional plot in Fig.
4 A shows the [Ca21] at z¼ 1 (the Z-line) plotted as a function
of radial position and time. The shaded region represents the
space within the dyadic cleft, where [Ca21]dyad rises to 300
mM (average concentration in the cleft; Fig. 4 C), or 2.1 mM
close to the channel opening (Fig. 4 B) for a short period of
time after the arrival of an action potential. These concen-
trations are at least 1000-fold higher than those experienced
in the bulk cytosol, and these excessive concentrations are
experienced almost exclusively in the dyad as a steep gra-
dient occurs at the junction between dyad and free cytosol
(Fig. 4 A). The inclusion of ATP as a diffusible Ca21 buffer
has dramatic effects on [Ca21]dyad within the cleft. Without
ATP diffusion the peak [Ca21]dyad is almost triple that ob-
served with ATP diffusion (data not shown). This agrees
with Michailova and McCulloch (7) in illustrating the
importance of ATP as a mobile Ca21 buffer.
Ratio of CaATP/MgATP within the cardiac dyad
during a calcium transient
In addition to predicting [Ca21]free, our model also calculates
the diffusion and concentration of ATP/CaATP/MgATP
during the Ca21 transient, so it is possible to calculate the
CaATP/MgATP ratio generated throughout the model cell.
Again the three foci of interest are the site of Ca21 entry (Fig.
5 A), the dyad averaged as a whole (Fig. 5 B), and the average
in the bulk cytosol (Fig. 5 C).
Although the ratio of CaATP/MgATP in the bulk cytosol
undergoes a modest increase (threefold change at its
maximum) as predicted by Michailova and McCulloch (7),
the ratio changes greatly in the dyad throughout the calcium
transient. At the point of Ca21 entry the CaATP/MgATP
ratio displayed a 2000-fold increase from an initial ratio of
9.4 3 105 to a ﬁnal ratio of 0.18. This represents a change
from an initial condition of 10,000 molecules of MgATP for
every molecule of CaATP, to a situation where there are only
six molecules of MgATP for every CaATP.
As would be expected, the CaATP/MgATP ratio observed
across the whole dyad changed substantially during a single
Ca21 transient; however the magnitude of change was less
than that observed at the channel mouth. The increase,
however, is still substantial being 650-fold at its height. Using
the prediction of the CaATP/MgATP generated within the
FIGURE 3 [Ca21]free transients generated by the mathematical model.
[Ca21]free was averaged throughout the cytosolic elements of the model.
(A) Transients 9 and 10 from a train of 20. (B) Transient generated on the
10th stimulation, expanded timescale from A.
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model along with the kinetic rates of CaATP and MgATP
binding to PKA, we next were able to estimate the occupancy
of PKA for either of the two metal ATP complexes (PKA-
CaATP, PKA-MgATP, and their ratio) (see Fig. 5, A and B).
We were further able to predict the impact of these changes
in metal ATP occupancy on PKA activity throughout the
sarcomere during a calcium transient.
The activity of PKA is reduced in the dyad of a
cardiac myocyte during contraction
Having previously deﬁned the relationship between PKA
activity and the CaATP/MgATP ratio in vitro, we were able
to use the CaATP/MgATP occupancy ratio of PKA to
calculate the activity of PKA at each time point, relative to
theoretical maximum activity of PKA, throughout the sar-
comere. Fig. 6 A shows the activity of PKA across the
t-tubule end of a sarcomere (z ¼ 1, Z-line) during a Ca21
transient. The shaded region illustrates the activity of PKA
within the dyad. There is a gradient of PKA activity across
the cleft, with maximal inhibition occurring at the point of
calcium entry (r ¼ 1). There is little or no effect on PKA
activity beyond the radius of the cleft. At the radial edge of
the cleft PKA, activity would only experience modest
inhibition (;10%) due to the CaATP/MgATP at the maxima
of the Ca21 transient. Thus, the oscillation in PKA activity in
neighboring regions (e.g., corbular SR, longitudinal SR)
would be slight. Fig. 6 B replots the activity of PKA at the
channel mouth showing the effect of varying the kinetics
of CaATP binding to PKA by 625%. It shows there is a
signiﬁcant reduction in PKA activity at the channel mouth
and that a 25% variation in CaATP-binding kinetics only
results in65% shift in the relative activity of PKA. The time
course of PKA inhibition within the cleft shows a maximal
inhibition of 55% occurring at the point of calcium entry (r¼
1). Fig. 6 C shows the average reduction in PKA activity
across the whole cleft, again with inclusion of a 25%
variation in CaATP-binding kinetics, here the reduction in
PKA activity is 40%. In both cases the peak inhibitory effect
occurs at 37 ms with maximal activity being returned around
200 ms, if one assumes a 1-Hz stimulatory frequency.
Integrating the data allows us to predict the level of
inhibition during both the whole and a portion of the
transient. At 1 Hz this equates to an 8% reduction in PKA
activity over the entire transient at the channel mouth (5%
across the whole dyad). If we were to assume an increased
stimulation frequency of 3 Hz (around that of exercising
humans), the contraction cycle would last 333 ms, through-
out which PKA activity would remain suppressed by 24% at
the channel mouth (14% across the whole dyad). Increasing
the frequency, yet higher, to that of small mammals (7 Hz)
shows a reduction in PKA activity of nearly 47% (channel
FIGURE 4 [Ca21] generated within
the dyad. (A) Three-dimensional plots
of [Ca21] at the Z-line (z ¼ 1) as a
function of time. The shaded region
represents the dyadic space. (B) [Ca21]
generated at r ¼ 1, akin to the 10-nm
space immediately surrounding the RYR
and DHPR channels. (C) [Ca21] aver-
aged across the whole of the dyad.
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mouth) for the duration of the transient (28% across the
whole dyad). As the rate of diffusion within the dyad is
essentially an informed estimate based upon the diffusion in
the free cytosol (5), we varied the dyadic diffusion coefﬁ-
cient to understand the impact an error in the original
estimate may have. Peskoff and Langer (5) assume that due
to the physical constants of diffusion (as described in the
introduction) within the dyad, the rate of diffusion will be a
third of that of the cytosol. Fig. 6, D and E, shows the
reduction in PKA activity predicted by our model if no such
reduction in diffusion is assumed within the dyad. Fig. 6 D
shows the effect at the channel mouth, with Fig. 6 E
illustrating the reduction in PKA activity throughout the
dyad. As could be expected an increase in the diffusion rate
blunts the magnitude of the reduction in PKA activity at both
locations, leading to peak reductions of 38% and 19% in
PKA activity located near to the channel mouth and through-
out the dyad, respectively. We also modeled the effect of
underestimating the restriction of diffusion within the dyad
by halving the rates proposed by Peskoff and Langer (5) (Fig.
6, F and G). Under these conditions the reduction in PKA
activity is magniﬁed, resulting in peak inhibitions of 65%
and 50% for PKA near the channel mouth and throughout the
dyad, respectively.
DISCUSSION
In this study, we sought to examine if the high [Ca21] in the
cardiac muscle dyadic space would inﬂuence the enzymatic
activity of a protein kinase that phosphorylates protein targets
resident in these spaces. PKA was shown to be inhibited at
high [Ca21] in a manner consistent with competitive inhibi-
tion of MgATP binding by CaATP. The physiological sig-
niﬁcance of these observations was explored using a
mathematical model of a ventricular myocyte (half) sarco-
mere. The model was generated using structurally accurate
subcellular compartments (dyadic volume) andkinetic param-
eters (ﬂuxes, buffering, diffusion). The model produced
physiological realistic cytosolic Ca21 transients. [Ca21]dyad
rose to concentrations exceeding 2 mM at sites close to the
channel mouth and peaked at 300 mM across the dyadic cleft.
This elevated [Ca21]dyad caused a pronounced shift in the
CaATP/MgATP ratio, which in turn was predicted to inhibit
PKA activity by 55% at the mouth of the channel and 40%
across the cleft. The extent of inhibition varied temporally and
was signiﬁcant for the ﬁrst 200 ms of a Ca21 transient, with
the average level of inhibition throughout the transient being
8% (calculated at a Ca21 transient frequency of 1 Hz). PKA
activity in the cytosol was unaffected by the modest elevation
in CaATP/MgATP in that space, even regions close to the
cleft, such as the corbular SRwould be unlikely to experience
inhibition of kinase activity, although it must be noted we do
not include Ca21 release from the corbular SR itself, which
could alter this conclusion.
Our experimental data show that increasing [Ca21] does
inhibit PKA by increasing the level of CaATP, as there is a
direct relationship between the activity of PKA and the
CaATP/MgATP ratio, independent of total [Ca21] or
[Mg21]. CaATP is likely acting as a competitive inhibitor
of MgATP binding to PKA.
We developed a computer simulation to predict the
changes in the [Ca21] and CaATP/MgATP ratio during a
Ca21 transient, generated in a ventricular myocyte. The model
was based upon Bazzazi et al. (27), with Ca21 buffering as
FIGURE 5 CaATP/MgATP generated within the model. (A and B) Ratios
within the dyad; broken line represents raw CaATP/MgATP ratio, bold
black line represents the PKA-CaATP/PKA-MgATP-bound occupancy ratio
using the same kinetics for both CaATP and MgATP binding to PKA. The
gray lines show the effect of varying CaATP-binding kinetics by625%. (A)
The ratio at r ¼ 1, (B) across the dyad as a whole, and (C) average ratio
throughout the cytosol.
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FIGURE 6 Transient inhibition of
PKA activity in the dyad. (A) Three-
dimensional plot of PKA activity at the
Z-line (z¼ 1) as a function of time. The
shaded region represents the dyadic
space. (B) PKA activity at r¼ 1, akin to
the 10-nm space immediately surround-
ing the RYR and DHPR channels and
(C) averaged across the whole of the
dyad. (D and E) As B and C, respec-
tively, with double the dyadic diffusion
rate. (F and G) As B and C, respec-
tively, with half the dyadic diffusion
rate. Black line represents equal CaATP
and MgATP kinetics; gray lines show
the effect of varying CaATP-binding
kinetics by 6 25%.
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described by Bers (10), with the addition of diffusible ATP
and ADP able to bind Ca21 or Mg21 (30) and kinetic binding
of CaATP and MgATP to PKA (24,31). Our model was able
to simulate Ca21 transients that replicated experimentally
derived transients (8), in terms of both concentration and dura-
tion. In the simulation, [Ca21]dyad rose to over 2 mM at the
Ca21 release site and 300mMaveraged across thewhole cleft.
These [Ca21]dyad are within the range predicted by some, but
not all, models of cardiac muscle (5,7–9). The discrepancy in
predicted [Ca21]dyad may relate to the representation of Ca
21
inﬂux as a ‘‘common pool’’ or ‘‘all-or-none’’ phenomenon
in some models (5,7,8) (ours included) as opposed to a
representation of entry asmultiple stochastic events leading to
more graded entries (9). We and others (5) used ﬁxed Ca21
entry derived experimentally, whereas other groups have used
a change in membrane potential to estimate Ca21 inﬂux (7,8).
Our [Ca21]dyad is also higher than that determined empirically
using Na21/Ca21 exchanger (NCX) currents to estimate near
membrane [Ca21] (32). The data presented in Fig. 4 suggest
that a steep [Ca21] gradient occurs at the edge of the dyad; this
coupled with the more recent data that NCXs are not localized
within the dyad (33) suggest that NCXs would underestimate
[Ca21]dyad. The effects of reducing the peak [Ca
21]dyad levels
to those proposed byMichailova andMcCulloch (30mM) (7)
are shown in Fig. 7, A and B. The 10-fold reduction in
proposed [Ca21]dyad reduces the inhibition of PKA by 50%,
(from 55% to 27%) at the Ca21 release site and by 70% (from
40% to 12%) throughout the dyad as a whole. Although the
effect on PKA activity is reduced under these conditions of
lower [Ca21]dyad, a 27% reduction in PKA activity could still
prove signiﬁcant. Fig. 7, C–F, shows the effect of varying
the diffusion rates within the dyad, at 30 mM [Ca21]dyad, as
previously discussed for 300 mM in the results.
Our model shows that the high [Ca21]dyad causes a sub-
stantial shift in the CaATP/MgATP ratio within the dyadic
cleft during a Ca21 transient. At diastole CaATP/MgATP is
FIGURE 7 Transient inhibition of
PKA activity in the dyad with reduced
[Ca21]dyad. PKA activity (A) at r ¼ 1,
akin to the 10-nm space immediately
surrounding the RYR and DHPR chan-
nels and (B) averaged across the whole
of the dyad, where [Ca21]dyad peaks
a 30 mM. (C and D) As A and B,
respectively, with double the dyadic
diffusion rate. (E and F) As A and B,
respectively, with half the dyadic dif-
fusion rate. Black line represents equal
CaATP andMgATP kinetics; gray lines
show the effect of varying CaATP-
binding kinetics by 6 25%.
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9.4 3 105, which quickly rises to 0.18 during systole. The
ratio at systole is comparable with those predicted previously
(34) in smooth muscle and in agreement with those predicted
in cardiac muscle (7). The rate at which the CaATP/MgATP
ratio alters over the initial 200 ms is faster than can be
accommodated by kinetic binding of CaATP or MgATP to
PKA. This leads to a delay between maximum of the CaATP/
MgATP ratio and the PKA-CaATP/PKA-MgATP-bound
ratio as is illustrated in Fig. 5, with the peak PKA-CaATP/
PKA-MgATP bound ratio being 0.14.
Combining the experimental data describing the relationship
of PKA activity and the CaATP/MgATP ratio with the sim-
ulated data predicting the bound PKA-CaATP/PKA-MgATP
ratio transient within the dyadic cleft allowed us to predict the
extent to which PKA activity would be reduced. The reduction
in PKA activity peaked at;55% and was maintained ;40%
for 100 ms at a stimulatory frequency of 1 Hz.
To understand the full implication of a 40%–55% transient
reduction in PKA activity on the phosphorylation status of
dyadic proteins, it is necessary to have estimates of the level of
activity (relative to theoretical maximum in vitro) required
to maintain or increase the phosphorylation of the various
proteins and channels residing in the dyadic cleft; however the
empirical information regarding this region is not currently
available. Our model does not attempt to predict the effect
increasing CaATP may have on other dyadic enzymes, such
as the phosphatases opposing PKA activity. Phosphatase
activity is unlikely to be modulated by an increase in CaATP,
as ATP is not a substrate, but the high [Ca21]dyad alone could
affect Ca21-dependent phosphatases, although the effect on
PKA described would be in addition to any other factors
modulating dyad phosphorylation status. Recent models (17)
have proposed that PKA is targeted to the dyad through
muscle A kinase anchoring protein (mAKAP) as part of the
RYRmacromolecular complex. If this is the case it would lead
to a high ratio of enzyme/substrate. This may counter some of
the effect of CaATP on PKA and reﬂect a requirement for
robust phosphorylation level of local proteins, although in this
PKA-targeted model, PKA would be localized near the
channel mouth and therefore experience the greatest level of
inhibition predicted by our simulation.
There are perhaps greater implications for the effect of
CaATP at higher stimulation frequencies. As there are no
major Ca21 removal mechanisms described as being located
within the dyadic cleft, the major factors inﬂuencing
[Ca21]dyad are Ca
21 entry and the diffusion rate through and
out of the dyad. This would suggest that at higher stimulation
frequencies (i.e., during exercise or those found in small
mammals), where diffusion rates and Ca21 entry would
remain the same, [Ca21]dyad would remain at elevated levels
for much more of the transient. At a contraction frequency of
;3 Hz (human during exercise) our current model would
suggest [Ca21]dyad remains ;10 mM for half of the contrac-
tion cycle, this would equate to a 14%–24% reduction in
activity even at diastole. In small mammals Peskoff et al. (6)
have suggested that at a frequency of ;7 Hz (a typical heart
rate of rats), the [Ca21]dyad remains above 100 mM for half of
the contraction cycle. This would lead to a chronic reduction
in PKA activity (;30% reduction during diastole), agreeing
well with the integration of our data, suggesting an average
reduction in PKA activity throughout a Ca21 transient at 7 Hz
stimulation frequency of 28%. It would be interesting to
examine what strategies are employed in these situations to
achieve rapid and efﬁcient phosphorylation of target proteins
in an environment unfavorable to protein kinase action.
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